Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics.
This study aimed to develop ultraflexible liposomes as an alternative to the oral route, which would enhance the bioavailability and reduce the toxicity of ethinylestradiol. Ultraflexible liposomes of ethinylestradiol using an optimized concentration of surfactants were prepared and characterized in vitro. The effect of surfactant type under non-occlusive conditions on transdermal permeability was assessed. A histopathological study was performed to assess the action of ethinylestradiol on the uterus and ovaries. The pharmacokinetics of free ethinylestradiol (following single oral administration and one day of application to the skin), ultraflexible liposomal ethinylestradiol and non-flexible liposomal ethinylestradiol were studied in female Sprague-Dawley rats. Insignificant differences in size between the ultraflexible liposomal formulations containing optimized concentrations of different surfactants were observed. Ultraflexible liposomes can penetrate through pores much smaller than their own diameter. The transdermal permeability of lipophilic surfactant was greater than that of hydrophilic surfactant. The release of ethinylestradiol from the proposed formulation through rat skin was found to be constant. The histopathological study showed that the ultraflexible liposomal transdermal drug delivery system for ethinylestradiol provided effective contraception by follicular cell lysis, depletion of zona granulosa and ova, and by increasing the uterine mucosal and endometrial proliferation. Encapsulation of ethinylestradiol in ultraflexible liposomes modified the pharmacodynamics and pharmacokinetics of the contraceptive agent, resulting in a marked improvement in bioavailability and optimized therapy.
Garg
Minakshi
M
Department of Pharmaceutical Sciences, Dr Hari Singh Gour University, Sagar 470003, India.
Mishra
Dinesh
D
Agashe
Hrushikesh
H
Jain
Narendra Kumar
NK
D000818:Animals; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D066298:In Vitro Techniques; D008081:Liposomes / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D010316:Particle Size; D018583:Pliability; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000187:drug effects / Q000378:metabolism
D008081:Liposomes; D004997:Ethinyl Estradiol